Literature DB >> 26886338

Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. I. Design of Experiments-Assisted Development.

Michela Mori1, Silvia Rossi2, Franca Ferrari1, Maria Cristina Bonferoni1, Giuseppina Sandri1, Theodora Chlapanidas1, Maria Luisa Torre1, Carla Caramella1.   

Abstract

The aim of the present work was the development of sponge-like dressings based on chitosan glutamate (high molecular weight) and sericin for the treatment of chronic skin ulcers. Dressings were prepared by freeze-drying and glycine was added as cryoprotectant agent. Dressing development was assisted by design of experiments, using a simplex centroid design. Mechanical resistance, hydration propensity, viscous, and viscoelasticity properties of dressings were considered as response variables. The superimposition of the contour plots, calculated by the best fit model for each response variable, permitted to individuate a region of the factor space where the dressing of optimized quantitative composition was chosen. Such a dressing was able to absorb high amount of phosphate-buffered saline forming a gel characterized by rheological properties enabling both a lubricant and a protective effect. The optimized formulation was characterized by optimal mechanical properties and by cell proliferation and antioxidant activity on human fibroblast cell line.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antioxidants; cell culture; chitosan; polymeric biomaterials; wound healing

Mesh:

Substances:

Year:  2016        PMID: 26886338     DOI: 10.1016/j.xphs.2015.11.047

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.

Authors:  Jacqueline Larouche; Sumit Sheoran; Kenta Maruyama; Mikaël M Martino
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

2.  In Vitro Effectiveness of Microspheres Based on Silk Sericin and Chlorella vulgaris or Arthrospira platensis for Wound Healing Applications.

Authors:  Elia Bari; Carla Renata Arciola; Barbara Vigani; Barbara Crivelli; Paola Moro; Giorgio Marrubini; Milena Sorrenti; Laura Catenacci; Giovanna Bruni; Theodora Chlapanidas; Enrico Lucarelli; Sara Perteghella; Maria Luisa Torre
Journal:  Materials (Basel)       Date:  2017-08-23       Impact factor: 3.623

3.  Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Authors:  Sabine François; Véronique Eder; Karim Belmokhtar; Marie-Christine Machet; Luc Douay; Norbert-Claude Gorin; Marc Benderitter; Alain Chapel
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

4.  Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis.

Authors:  Silvia Rossi; Barbara Vigani; Antonella Puccio; Maria Cristina Bonferoni; Giuseppina Sandri; Franca Ferrari
Journal:  Mar Drugs       Date:  2017-10-19       Impact factor: 5.118

5.  Development of a Mucoadhesive and an in Situ Gelling Formulation Based on κ-Carrageenan for Application on Oral Mucosa and Esophagus Walls. II. Loading of a Bioactive Hydroalcoholic Extract.

Authors:  Barbara Vigani; Silvia Rossi; Matteo Gentile; Giuseppina Sandri; Maria Cristina Bonferoni; Valeria Cavalloro; Emanuela Martino; Simona Collina; Franca Ferrari
Journal:  Mar Drugs       Date:  2019-03-05       Impact factor: 5.118

6.  An In Situ Gelling System for the Local Treatment of Inflammatory Bowel Disease (IBD). The Loading of Maqui (Aristotelia Chilensis) Berry Extract as an Antioxidant and Anti-Inflammatory Agent.

Authors:  Marika Tenci; Silvia Rossi; Valentina Giannino; Barbara Vigani; Giuseppina Sandri; Maria Cristina Bonferoni; Maria Daglia; Luigi Maria Longo; Cristina Macelloni; Franca Ferrari
Journal:  Pharmaceutics       Date:  2019-11-14       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.